GlassScriptPhysician profile
Reed L Levine
NPI 1386844868
$99,355.24
in general payments reported to CMS, 2019-2025
49 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,116 · 2021: $11K · 2022: $4,748 · 2023: $3,748 · 2024: $5,489 · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $11K · Travel and Lodging: $7,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,537.50 |
| Food and Beverage | $10,762.14 |
| Travel and Lodging | $7,476.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $43,736.31 | 2025 | |
| Biodelivery Sciences International, INC. | $12,317.72 | 2019-2021 | |
| Abbott Laboratories | $7,204.44 | 2019-2025 | Proclaim, Eterna |
| Mdd US Operations, LLC | $6,482.71 | 2019 | |
| Biogen, INC. | $6,300.64 | 2019 | |
| Medtronic, INC. | $5,731.92 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $3,250.53 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Spinal Simplicity, LLC | $2,677.69 | 2022-2025 | Ha Minuteman G3-R, Liberty Si |
| Redhill Biopharma INC. | $1,716.72 | 2020-2022 | |
| Uswm, LLC | $1,550.29 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,248.97 | 2019-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $945.91 | 2019-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $896.73 | 2021-2025 | Sprint Pns System |
| Abbvie INC. | $743.70 | 2021-2025 | |
| Biotronik Nro, INC. | $576.85 | 2024-2025 | Prospera |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $490.76 | 2021-2025 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $300.82 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Biohaven Pharmaceuticals, INC. | $249.31 | 2021 | |
| Pfizer INC. | $230.65 | 2019-2025 | |
| Mml US, INC. | $225.33 | 2025 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $207.12 | 2019-2024 | Ztlido |
| Horizon Therapeutics Plc | $189.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $173.71 | 2019-2021 | |
| Lundbeck LLC | $164.81 | 2023-2025 | Vyepti |
| Painteq LLC | $151.80 | 2022-2023 | Painteq |
| Lilly USA, LLC | $143.21 | 2019-2024 | Emgality |
| Nevro Corp. | $142.79 | 2022-2023 | Senza |
| Assertio Therapeutics, INC. | $126.20 | 2019 | |
| Almatica Pharma LLC | $125.68 | 2021-2023 | Loreev Xr |
| Virtus Pharmaceuticals LLC | $108.34 | 2021-2024 | Levorphanol Tartrate |
| Biohaven Pharmaceutical Holding Company LTD. | $107.48 | 2022 | |
| Protega Pharmaceutials INC | $101.14 | 2025 | Roxybond |
| Teva Pharmaceuticals USA, INC. | $99.91 | 2019 | |
| Allergan, INC. | $84.08 | 2021 | |
| Saluda Medical Americas, INC. | $67.40 | 2023-2025 | Evoke, Evoke Scs |
| Globus Medical, INC. | $57.59 | 2023-2025 | Senza, Allocate |
| Curonix LLC | $51.35 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Piramal Critical Care | $48.56 | 2021 | |
| Amgen INC. | $39.24 | 2021-2022 | |
| Bioventus LLC | $38.53 | 2022 | |
| Hikma Pharmaceuticals USA | $37.73 | 2022 | |
| Vertical Pharmaceuticals, LLC | $36.33 | 2019 | |
| Medtronic USA, INC. | $35.88 | 2019 | |
| Grt US Holding, INC. | $34.81 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $24.24 | 2023 | Dysport |
| Si-Bone, INC. | $22.18 | 2023 | |
| Ibsa Pharma INC. | $21.60 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.89 | 2019 | |
| Shionogi INC | $17.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reed Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.